Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Opioid Settlement Advisory Committee topic

No spam. Unsubscribe anytime.

Chair moves to enter executive session to review opioid settlement funds advisory committee applications

April 9, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The chair moved to enter executive session under Title 1 M.R.S.A. §405(6)(A) to review applications for an opioid settlement funds advisory committee; the motion was seconded and approved by a voice vote of three "Aye" responses.

At the meeting, the chair moved to enter an executive session to review and discuss applications for an opioid settlement funds advisory committee, citing Title 1 M.R.S.A. §405(6)(A).

The advisory committee applications were the stated reason for the closed-session request, an item of public interest because such committees typically advise on the use or oversight of settlement funds tied to opioid litigation.

The chair made the motion, saying, "I'm gonna move into executive session as permitted by title 1 MRSA sub section 405 subsection 6 a to review and discuss the opioid settlement funds advisory committee applications." The chair then added, "I'll second that." The chair called for those in favor, and three participants responded "Aye," approving the motion by voice vote.

Following the vote, the meeting moved into executive session. No additional details about the applications or any actions taken in the closed session were provided on the public record during the transcript.